/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

Douglas R. Adkins

Washington University in St. Louis(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

537

Papers

14.3K

Citations

53

h-index

179

i10-index

Douglas R. Adkins is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Head and Neck Cancer Studies & Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers. The author has an h-index of 53, co-authored 457 publications.

ORCID: 0000-0003-3207-8227

Research Topics

Head and Neck Cancer Studies Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immune Cell Function and Interaction

Papers by this author

works

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

2018 · The Lancet · 1,656 citations

https://doi.org/10.1016/s0140-6736(18)31999-8

Ezra E.W. Cohen Denis Soulières Christophe Le Tourneau José Dinis

NCCN Guidelines Insights: Bone Cancer, Version 2.2017

2017 · Journal of the National Comprehensive Cancer Network · 291 citations

https://doi.org/10.6004/jnccn.2017.0017

J. Sybil Biermann Warren Chow Damon R. Reed David R. Lucas

Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

2023 · Nature Communications · 123 citations

https://doi.org/10.1038/s41467-023-37266-6

Kelsy C. Cotto Yang-Yang Feng Avinash Ramu Megan M. Richters

A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas

2016 · Cell Death and Disease · 99 citations

https://doi.org/10.1038/cddis.2016.232

Gregory R. Bean Jeff C. Kremer Bethany C. Prudner Aaron Schenone

Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma

2017 · International Journal of Radiation Oncology*Biology*Physics · 79 citations

https://doi.org/10.1016/j.ijrobp.2017.10.019

Carryn M. Anderson Stephen T. Sonis Christopher M. Lee Douglas R. Adkins

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

2010 · Cancer Chemotherapy and Pharmacology · 68 citations

https://doi.org/10.1007/s00280-010-1410-1

Paula M. Fracasso Kerry J. Williams Ronald C. Chen Joel Picus

Research topics

topics

Head and Neck Cancer Studies

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

CAR-T cell therapy research

Immune Cell Function and Interaction

Chat about Author

Papers

Chat

Click to start Chat